<P>This statement was in a recent press release for vx-770</P>
<P> </P>
<P>Vertex plans to make VX-770 available to the G551D mutation subpopulation prior to potential FDA approval, as early as July, pending FDA review and approval.</P>
<P> </P>
<P>Does this mean that it will be available for everyone that has the mutation as early as July? My son has G551D and we are anxiously awaiting FDA approval. </P>
<P> </P>
<P> </P>
<P> </P>
<P>Vertex plans to make VX-770 available to the G551D mutation subpopulation prior to potential FDA approval, as early as July, pending FDA review and approval.</P>
<P> </P>
<P>Does this mean that it will be available for everyone that has the mutation as early as July? My son has G551D and we are anxiously awaiting FDA approval. </P>
<P> </P>
<P> </P>